Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
ACS Medicinal Chemistry Letters|October 15, 2025
Structure-Guided Temporin L Analogs Development to Inhibit the Main Protease of SARS-CoV‑2James Stewart, Ruoqing Jia, Md Ackas Ali, et al.
Food Science & Nutrition|December 2, 2024
Cardioprotective action of apocynin in isoproterenol-induced cardiac damage is mediated through Nrf-2/HO-1 signaling pathwayMd Mizanur Rahman, Mirza Alimullah, Tahmina Yasmin, et al.
New Journal of Chemistry = Nouveau Journal De Chimie|July 2, 2026
Spectroscopic, Thermal and Mass Spectrometry Investigations of Mechanochemically Synthesized Deep Eutectic SolventsOluseyi Olawuyi, Sabbir Ahmed, Momena Begum, et al.
Journal of Computational Chemistry|September 30, 2021
Repurposing fusion inhibitor peptide against SARS-CoV-2Faiyaz Md Efaz, Shafiqul Islam, Shafi Ahmad Talukder, et al.
Chemical Science|May 8, 2018
Mass and charge distributions of amyloid fibers involved in neurodegenerative diseases: mapping heterogeneity and polymorphismJonathan Pansieri, Mohammad A Halim, Charlotte Vendrely, et al.
Journal of Biomolecular Structure & Dynamics|September 30, 2021
Identification of potent inhibitors against transmembrane serine protease 2 for developing therapeutics against SARS-CoV-2Abdulla Al Mamun, Farjana Akter, Maksud Khan, et al.
ACS Omega|October 2, 2023
Therapeutic Potential of Antiviral Peptides against the NS2B/NS3 Protease of Zika VirusMd Shahadat Hossain, Md Tanjil Islam Shovon, Md Rafid Hasan, et al.
The Journal of Physical Chemistry. B|October 23, 2020
Antiviral Peptides as Promising Therapeutics against SARS-CoV-2Surid Mohammad Chowdhury, Shafi Ahmad Talukder, Akib Mahmud Khan, et al.
Journal of Computational Chemistry|December 8, 2022
Large scale peptide screening against main protease of SARS CoV-2Md Jaish Uddin, Hasina Akhter, Urmi Chowdhury, et al.
Pageof 8